Free Trial

Globe Life (NYSE:GL) Reaches New 1-Year High - Here's What Happened

Globe Life logo with Finance background
Remove Ads

Globe Life Inc. (NYSE:GL - Get Free Report)'s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $131.41 and last traded at $130.65, with a volume of 57668 shares trading hands. The stock had previously closed at $129.90.

Analysts Set New Price Targets

Several analysts have weighed in on the company. BMO Capital Markets initiated coverage on Globe Life in a research note on Thursday, January 23rd. They set a "market perform" rating and a $114.00 target price on the stock. Morgan Stanley boosted their price target on shares of Globe Life from $125.00 to $126.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Keefe, Bruyette & Woods raised their price objective on shares of Globe Life from $137.00 to $145.00 and gave the company an "outperform" rating in a research note on Wednesday, February 12th. Evercore ISI raised Globe Life from an "in-line" rating to an "outperform" rating and increased their price target for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company lifted their target price on Globe Life from $126.00 to $141.00 and gave the stock an "overweight" rating in a report on Wednesday, February 19th. Five research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $135.60.

Read Our Latest Research Report on GL

Remove Ads

Globe Life Trading Down 1.3 %

The company has a fifty day moving average of $123.98 and a 200-day moving average of $113.91. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. The firm has a market capitalization of $10.79 billion, a PE ratio of 10.85 and a beta of 0.77.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating analysts' consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. On average, sell-side analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.83%. The ex-dividend date of this dividend is Thursday, April 3rd. This is a boost from Globe Life's previous quarterly dividend of $0.24. Globe Life's payout ratio is currently 9.04%.

Insider Transactions at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 11,000 shares of the company's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $122.31, for a total value of $1,345,410.00. Following the sale, the chief executive officer now directly owns 18,948 shares in the company, valued at $2,317,529.88. This represents a 36.73 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CMO Jennifer Allison Haworth sold 9,000 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the sale, the chief marketing officer now owns 13,485 shares of the company's stock, valued at $1,522,591.35. This trade represents a 40.03 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 61,338 shares of company stock worth $7,239,630 over the last three months. 1.51% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Globe Life

A number of large investors have recently bought and sold shares of GL. Wellington Management Group LLP raised its holdings in shares of Globe Life by 6.8% in the fourth quarter. Wellington Management Group LLP now owns 5,117,122 shares of the company's stock valued at $570,661,000 after buying an additional 326,307 shares during the last quarter. Invesco Ltd. lifted its position in shares of Globe Life by 6.0% during the fourth quarter. Invesco Ltd. now owns 3,932,637 shares of the company's stock worth $438,568,000 after purchasing an additional 223,282 shares in the last quarter. State Street Corp grew its stake in shares of Globe Life by 3.4% during the third quarter. State Street Corp now owns 3,545,272 shares of the company's stock valued at $375,480,000 after purchasing an additional 115,432 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Globe Life by 3.5% during the 3rd quarter. Geode Capital Management LLC now owns 2,618,764 shares of the company's stock worth $276,994,000 after buying an additional 89,299 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Globe Life by 8.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,592,734 shares of the company's stock worth $177,615,000 after purchasing an additional 118,054 shares during the period. 81.61% of the stock is currently owned by institutional investors.

About Globe Life

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

See Also

Should You Invest $1,000 in Globe Life Right Now?

Before you consider Globe Life, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.

While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Related Videos

Will Tesla’s Robot Future Save Its Falling Stock?
Tesla Sinks on Musk Drama—Bounce or Bigger Crash?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads